James Mock
Förmögenhet: 10 M $ per 2026-08-31
Förmögenhet: 10 M $ per 2026-08-31
James M.
Mock is currently Chief Financial Officer at Moderna, Inc. since 2022.
Formerly, Mr. Mock was Chief Financial Officer & Senior Vice President at Revvity, Inc. from 2018 to 2022, Vice President at GE Aerospace from 2015 to 2018, and Chief Financial Officer & Vice President at Baker Hughes Energy Services LLC from 2014 to 2015.
Mr. Mock completed undergraduate education at St. Lawrence University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
MODERNA, INC. 0,02 % | 2026-09-04 | 74 375 ( 0,02 % ) | 10 M $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| MODERNA, INC. | Finansdirektör/CFO | 2022-09-06 |
| Företag | Position | Slut |
|---|---|---|
| REVVITY, INC. | Finansdirektör/CFO | 2022-09-05 |
| GE AEROSPACE | Företagsledare/Principal | 2018-04-01 |
Baker Hughes Energy Services LLC
Baker Hughes Energy Services LLC Wholesale DistributorsDistribution Services Wholesales petroleum and related products | Finansdirektör/CFO | 2015-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
GE Aerospace
GE Aerospace Aerospace & DefenseElectronic Technology Designs, develops, manufactures and services aircraft engines for commercial airframes & defense jet engines, avionics & power systems | Electronic Technology |
Revvity, Inc.
Revvity, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes reagents, analytical instruments and develops software | Health Technology |
St. Lawrence University
St. Lawrence University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baker Hughes Energy Services LLC
Baker Hughes Energy Services LLC Wholesale DistributorsDistribution Services Wholesales petroleum and related products | Distribution Services |
Moderna, Inc.
Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån